Login / Signup

Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of Study Participants.

Virginia SolitanoHeather PrinsMeagan ArcherLeonardo GuizzettiVipul Jairath
Published in: Crohn's & colitis 360 (2024)
These results should help inform the design of future clinical trials with a focus on patient-centricity.
Keyphrases
  • clinical trial
  • patients with inflammatory bowel disease
  • case report
  • study protocol
  • phase ii
  • open label
  • randomized controlled trial
  • phase iii